By Vesica Health, Inc. Major milestone affirms the clinical utility of AssureMDx in early bladder cancer detection
|
 | By IGH Naturals Selected patients preparing for chemotherapy will receive HuMOLYTE at no cost and provide feedback to support product development.
|
By SterileCare Inc New data highlights KiteLock's role in improving patient outcomes and reducing healthcare costs
|
By Meaningful Insights Biotech Analytics (MiBA) Matt Hagan Named Vice President of Marketing and Client Innovation
|
By Infonet 4th International Cancer Expo and Conference welcomes you as our guest to the City of Philadelphia
|
By KL Krems Nuclear protein Ki67 suitable as a biomarker for pleural mesothelioma. International study by Karl Landsteiner University of Health Sciences confirms Ki67's high informative value for tumour aggressiveness and surgical treatment success.
|
 | By W. Montague Cobb NMA Health Institute The W. Montague Cobb Institute mourns the sudden and untimely loss of world-renowned cancer researcher and Vice-Chair of its Board of Directors. Dr.
|
By Lacort Medical VI Congreso Oncología Integral Lacort Medical Avances y Perspectivas
|
